Acquired von Willebrand syndrome associated with cardiovascular diseases
H Horiuchi, T Doman, K Kokame, Y Saiki… - … of atherosclerosis and …, 2019 - jstage.jst.go.jp
304 lets, GPIIb/IIIa (integrin αIIbβ3) that is abundantly present on platelets changes its
conformation to allow it to bind its ligands, VWF and fibrinogen20, 21). A part (~ 30%) of …
conformation to allow it to bind its ligands, VWF and fibrinogen20, 21). A part (~ 30%) of …
A fully magnetically levitated left ventricular assist device
MR Mehra, N Uriel, Y Naka… - … England Journal of …, 2019 - Mass Medical Soc
Background In two interim analyses of this trial, patients with advanced heart failure who
were treated with a fully magnetically levitated centrifugal-flow left ventricular assist device …
were treated with a fully magnetically levitated centrifugal-flow left ventricular assist device …
The unique blood pressures and pulsatility of LVAD patients: current challenges and future opportunities
An increasing number of end-stage heart failure patients are now implanted with continuous-
flow left ventricular assist devices (CF-LVADs). Although this therapeutic approach is …
flow left ventricular assist devices (CF-LVADs). Although this therapeutic approach is …
Primary results of long‐term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist …
MR Mehra, JC Cleveland Jr, N Uriel… - European journal of …, 2021 - Wiley Online Library
Aim The MOMENTUM 3 pivotal trial established superiority of the HeartMate 3 (HM3) left
ventricular assist device (LVAD), a fully magnetically levitated centrifugal‐flow pump, over …
ventricular assist device (LVAD), a fully magnetically levitated centrifugal‐flow pump, over …
Hemocompatibility-related outcomes in the MOMENTUM 3 trial at 6 months: a randomized controlled study of a fully magnetically levitated pump in advanced heart …
N Uriel, PC Colombo, JC Cleveland, JW Long… - Circulation, 2017 - Am Heart Assoc
Background: The HeartMate 3 (HM3) Left Ventricular Assist System (LVAS)(Abbott) is a
centrifugal, fully magnetically levitated, continuous-flow blood pump engineered to enhance …
centrifugal, fully magnetically levitated, continuous-flow blood pump engineered to enhance …
Fluid dynamics in the HeartMate 3: influence of the artificial pulse feature and residual cardiac pulsation
L Wiegmann, B Thamsen, D De Zélicourt… - Artificial …, 2019 - Wiley Online Library
Ventricular assist devices (VADs), among which the HeartMate 3 (HM3) is the latest clinically
approved representative, are often the therapy of choice for patients with end‐stage heart …
approved representative, are often the therapy of choice for patients with end‐stage heart …
Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure–1 year results from the Ce mark trial
Abstract Background The HeartMate 3 Left Ventricular Assist System (LVAS)(St. Jude
Medical Inc., St Paul, MN) with full magnetic levitation allows for wide and consistent blood …
Medical Inc., St Paul, MN) with full magnetic levitation allows for wide and consistent blood …
Hospitalization patterns and impact of a magnetically-levitated left ventricular assist device in the MOMENTUM 3 trial
H Vidula, K Takeda, JD Estep, SC Silvestry, C Milano… - Heart Failure, 2022 - jacc.org
Abstract Background In the MOMENTUM 3 (Multicenter Study of MagLev Technology in
Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3) pivotal trial …
Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3) pivotal trial …
Long‐term evaluation of a fully magnetically levitated circulatory support device for advanced heart failure—two‐year results from the HeartMate 3 CE Mark Study
JD Schmitto, Y Pya, D Zimpfer… - European journal of …, 2019 - Wiley Online Library
Aim This study aimed to assess safety and outcomes of patients, 2 years after implantation
with the HeartMate 3 Left Ventricular Assist System. Methods and results This study included …
with the HeartMate 3 Left Ventricular Assist System. Methods and results This study included …
Left ventricular assist devices: a primer for the general cardiologist
SP Chaudhry, AD DeVore, H Vidula… - Journal of the …, 2022 - Am Heart Assoc
Durable implantable left ventricular assist devices (LVADs) have been shown to improve
survival and quality of life for patients with stage D heart failure. Even though LVADs remain …
survival and quality of life for patients with stage D heart failure. Even though LVADs remain …